ARA-290 – 10 MG

*COMES IN LYOPHILIZED POWDER FORM MUST RECONSTITUE*

ARA-290 (Cibinetide)

ARA-290, also known as Cibinetide, is a synthetic 11-amino acid peptide derived from the tissue-protective domain of erythropoietin (EPO). It is engineered to activate the innate repair receptor (IRR) while eliminating the red blood cell-stimulating (erythropoietic) effects of EPO.

Key Benefits: • Reduces neuropathic pain and supports nerve repair • Improves symptoms of small fiber neuropathy and diabetic neuropathy • Promotes tissue protection and regeneration • Lowers inflammation and modulates immune response • Supports metabolic health and microvascular function • Enhances corneal nerve fiber density and autonomic function

How It Works ARA-290 selectively binds to the innate repair receptor (a heteromer of the EPO receptor and β-common receptor), triggering anti-inflammatory, anti-apoptotic, and tissue-repair pathways. It helps reprogram damaged tissue environments from pro-inflammatory to healing states without affecting hematocrit or causing EPO-related side effects.

Why Choose ARA-290?

• Targets the root mechanisms of nerve damage and chronic inflammation
• Backed by multiple clinical studies in neuropathy, diabetes, and sarcoidosis
• Excellent safety profile with no significant adverse effects reported in trials
• Ideal for research in neuropathic pain, tissue repair, and regenerative protocols

Product Highlights:

• High-purity research-grade peptide
• Available as lyophilized powder for maximum stability
• Reconstitutes easily for subcutaneous or custom formulations
• Stable when properly stored (refrigerate or freeze lyophilized form)

Note: ARA-290 is intended for research and educational purposes only. Consult a qualified healthcare professional before any use.